
IBSA Group is a Swiss multinational pharmaceutical Company, founded in 1945 in Lugano. Today, its products are present in over 90 Countries on 5 continents, through the Company’s 20 subsidiaries located in Europe, China, and the United States.
IBSA Group employs over 2,300 people between headquarters, subsidiaries and production sites. IBSA holds 90 families of approved patents, plus others under development, as well as a vast portfolio of products, covering 10 therapeutic areas: reproductive medicine, endocrinology, pain and inflammation, osteoarticular, aesthetic medicine, dermatology, urogynecology, cardiometabolic, respiratory, and consumer health. With a strong global presence, it plays a leading role in reproductive medicine and continues to set benchmarks in hyaluronic acid-based therapies.
IBSA has based its philosophy on four pillars: Person, Innovation, Quality and Responsibility.
IBSA established a presence in the United States as IBSA USA in 2018 to expand access to its innovative treatments for hypothyroidism and pain management. IBSA USA is committed to bringing other innovative therapeutic products to the United States market.